What is the antidote for Lovenox (enoxaparin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The antidote for Lovenox (enoxaparin) is protamine sulfate, which should be administered intravenously to neutralize its anticoagulant effects in cases of significant bleeding. When a patient experiences significant bleeding while on Lovenox, protamine sulfate can be used to partially reverse its effects. The dosing of protamine sulfate depends on the timing of the last Lovenox dose:

  • 1 mg of protamine per 1 mg of Lovenox if given within 8 hours,
  • or 0.5 mg of protamine per 1 mg of Lovenox if given within 8–12 hours 1. Protamine can only partially neutralize Lovenox, which is less effective than its complete reversal of unfractionated heparin. This partial neutralization occurs because protamine primarily binds to the longer chains in Lovenox's molecular structure.
  • Healthcare providers should monitor patients closely after administration for signs of bleeding resolution and potential adverse reactions to protamine,
  • which can include hypotension, bradycardia, and allergic reactions 1. Patients with fish allergies or previous protamine exposure may have increased risk of allergic reactions.
  • It is essential to note that the clinical significance of incomplete anti-Xa neutralization of LMWH by protamine sulfate is unclear,
  • and the use of protamine sulfate is based on a strong recommendation with moderate quality evidence 1. In cases where life-threatening bleeding persists, or the patient has renal insufficiency, redosing protamine may be considered 1.

From the FDA Drug Label

Injected enoxaparin sodium may be largely neutralized by the slow intravenous injection of protamine sulfate (1% solution) The dose of protamine sulfate should be equal to the dose of enoxaparin sodium injected: 1 mg protamine sulfate should be administered to neutralize 1 mg enoxaparin sodium, if enoxaparin sodium was administered in the previous 8 hours.

The antidote for Lovenox (enoxaparin) is protamine sulfate.

  • The dose of protamine sulfate should be equal to the dose of enoxaparin sodium injected.
  • 1 mg protamine sulfate should be administered to neutralize 1 mg enoxaparin sodium, if enoxaparin sodium was administered in the previous 8 hours 2.
  • Note that the anti-Factor Xa activity is never completely neutralized (maximum about 60%) 2.

From the Research

Lovenox Antidote

  • Lovenox, also known as enoxaparin, is a low-molecular-weight heparin (LMWH) used as an anticoagulant to prevent and treat blood clots.
  • The antidote for Lovenox is protamine sulfate, which can partially reverse its anticoagulant effects 3, 4, 5, 6.
  • Protamine sulfate is more effective in neutralizing the bleeding side-effects of enoxaparin than its anti-factor Xa activity 3, 5.
  • The dosage of protamine sulfate for reversing enoxaparin-induced bleeding may depend on the time from last administration and dose of enoxaparin, as well as the patient's renal function and anti-Xa assay results 4, 7.
  • While protamine sulfate can reduce bleeding induced by enoxaparin, it may not completely reverse its anticoagulant activity 3, 7, 5, 6.
  • Other treatments, such as transfusion of blood products and use of specific antidotes, may be necessary in cases of major bleeding related to enoxaparin 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2017

Research

Management of an unintentional enoxaparin overdose: A case report and literature review.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.